Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-03-12

FDA Approved: VALGANCICLOVIR — Supplemental Application (Strides Pharma Science Limited)

View source ↗

Summary

FDA approved a supplemental application for valganciclovir hydrochloride (generic product) from Strides Pharma Science Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Valganciclovir hydrochloride (VALGANCICLOVIR HYDROCHLORIDE)

Snippet

SUPPL AP for VALGANCICLOVIR (VALGANCICLOVIR HYDROCHLORIDE)